A Glass of hope

A Glass of hope

Yes, we know this hasn’t been the best of times for our wine drinking friends in France. Yes, the Sanofi (NYSE: SNY) diabetes franchise is going nowhere in a hurry resulting in a game of management musical chairs. The goose that laid the golden eggs is on its way to being a dead duck, the MannKind (NASDAQ: MNKD) partnership like Apidra and the once way cool and now way dead iBGStar have been complete failures. LixiLan is just a new disaster waiting to happen and the pipeline is full of nothing but me-too copycat late to market compounds.

Yet our good buddy Serge and his partner in disaster Olivier should take comfort that there may be light at the end of the tunnel which isn’t the freight train everyone thought it was. According to a study published in the Journal of Diabetes Investigation researchers concluded that any amount of wine — with certain precautions — can have a positive effect for type 2 diabetes. That’s right these researchers found that wine, heck even beer, can have a beneficial impact for patients with diabetes.

According to a story published by Diabetes in Control;

“Wine consumption yielded a 15% reduced risk for type 2 diabetes, beer consumption yielded a slight decrease in the risk and spirit consumption yielded a slight reduction, although not significant. In an additional analysis for amount of consumption (low, 0-10 g/day; moderate, 10-20 g/day; high, > 20 g/day), any amount of wine was linked to a significant decreased risk for type 2 diabetes. Moderate beer consumption had a greater effect for reducing the risk for type 2 diabetes compared with the low consumption, but there was no decreased risk with beer consumption in the high category.”

The story did not mention just which type of wine yielded the best results or whether lite beer out performed say a craft beer but still this has to be good news for our wine drinking friends. Now Sanofi may not know jack about how to run a diabetes franchise but the French certainly know a thing or two about wine.

Diabetic Investor has not yet had time to consult with our beautiful wine expert to get her opinion of this study but we will when time permits. For example, it would be interesting to know if a buttery Chardonnay produces better results than say a big and bold Cabernet. We’d also like to know given the high cost of wine whether cheaper boxed wine performs as well as the stuff in bottles. While we’re at it what about Pinot Noir, Chianti, champagne or other wines. We all know wine drinkers are as varied as people with diabetes so it would foolish to assume that just Chardonnay’s or Cabernet’s do the trick.

Now Diabetic Investor can perfectly handle the beer questions and could easily assemble our own panel of beer drinkers to delve deeper into this issue.

Crazy thing is even other spirits seemed to show beneficial effects. Again the story did not mention if say Makers Mark outperformed Grey Goose but we have no doubt that this pressing question will get answered with further study.

But think about this for a moment as Sanofi has a huge edge here over Lilly (NYSE: LLY) who’s headquartered in Indianapolis, Indiana not exactly known for wine, Novo Nordisk (NYSE: NVO) is headquartered in Denmark another non-wine area while AstraZeneca (NYSE: AZN) is headquartered in London which is known for many things wine is not among them.

We can just see Serge and Olivier salivating over this news and are at this very moment scouring the French countryside looking for French winemakers they can partner with or acquire. Given the high incidence rate of diabetes in the USA we suspect it won’t be long before Serge and Olivier hoop on the corporate Gulfstream and head to Napa looking for American partners. Think of the fun times and the free samples they would get. Yes, they can bask in the beautiful Napa sunshine, drink some damn good wine all on the corporate dime.

This whole situation reminds of something Momma Kliff used to say; “When you least expect it something happens that you have nothing to do with yet could ultimately save your ass and cover up all the mistakes you made in the past. Remember if you spread enough manure around something is bound to grow eventually no matter how bad the soil.” And let’s be honest here when it comes to diabetes Sanofi has spread around their fair share of manure.